OMX Nordic 40
2.433,59
PKT
+21,23
PKT
+0,88
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
| 04.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 04.06.19 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca Sell | UBS AG | |
| 31.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 30.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 24.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 24.05.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 24.05.19 | AstraZeneca overweight | Barclays Capital | |
| 21.05.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 17.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 17.05.19 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
| 17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 14.05.19 | Volvo (B) Underperform | Merrill Lynch & Co., Inc. | |
| 14.05.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 13.05.19 | AstraZeneca Sell | UBS AG | |
| 13.05.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 10.05.19 | AstraZeneca buy | Deutsche Bank AG | |
| 10.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 07.05.19 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 07.05.19 | AstraZeneca Sell | UBS AG | |
| 07.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
| 07.05.19 | Novo Nordisk Reduce | HSBC | |
| 06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. |